Armata Pharmaceuticals (ARMP) Operating Income Growth (3y) (2016 - 2026)
Armata Pharmaceuticals (ARMP) Operating Income Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 55.96% |
| 10 | Armata Pharmaceuticals | 171.69 Mn | 166.89 Mn | - | 8.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.17% |
| Dec 31, 2025 | -10.20% |
| Sep 30, 2025 | 3.39% |
| Jun 30, 2025 | 9.46% |
| Mar 31, 2025 | 2.27% |
| Dec 31, 2024 | -20.34% |
| Sep 30, 2024 | -16.67% |
| Jun 30, 2024 | -24.35% |
| Mar 31, 2024 | -23.46% |
| Dec 31, 2023 | -14.07% |
| Sep 30, 2023 | -22.50% |
| Jun 30, 2023 | -28.01% |
| Mar 31, 2023 | -32.11% |
| Dec 31, 2022 | -33.14% |
| Sep 30, 2022 | -8.36% |
| Jun 30, 2022 | -21.36% |
| Mar 31, 2022 | -36.62% |
| Dec 31, 2021 | -29.36% |
| Sep 30, 2021 | -36.24% |
| Jun 30, 2021 | -29.65% |